PharmaLundensis AB (XSAT:PHAL) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is PharmaLundensis AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. PharmaLundensis AB's Free Cash Flow for the three months ended in Mar. 2024 was kr-0.97 Mil. PharmaLundensis AB's Revenue for the three months ended in Mar. 2024 was kr0.00 Mil. Therefore, PharmaLundensis AB's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, PharmaLundensis AB's current FCF Yield % is -13.30%.

The historical rank and industry rank for PharmaLundensis AB's FCF Margin % or its related term are showing as below:

XSAT:PHAL's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -139.09
* Ranked among companies with meaningful FCF Margin % only.

PharmaLundensis AB FCF Margin % Historical Data

The historical data trend for PharmaLundensis AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaLundensis AB FCF Margin % Chart

PharmaLundensis AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

PharmaLundensis AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of PharmaLundensis AB's FCF Margin %

For the Biotechnology subindustry, PharmaLundensis AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaLundensis AB's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaLundensis AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where PharmaLundensis AB's FCF Margin % falls into.

PharmaLundensis AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

PharmaLundensis AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	0	/	0
	=	%

PharmaLundensis AB's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-0.972	/	0
	=	%

PharmaLundensis AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of PharmaLundensis AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaLundensis AB (XSAT:PHAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Medicon Village, Scheelevagen 2, Lund, SWE, 22381

Website

http://www.pharmalundensis.se

PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.

PharmaLundensis AB (XSAT:PHAL) Headlines

No Headlines